Navigation Links
Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
Date:8/20/2012

SOLANA BEACH, Calif., Aug. 20, 2012 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (OTC Markets Group: IMMY), a specialty pharmaceutical company developing non-invasive, topically delivered products, announced that it has signed an agreement with DPT Labs (www.dptlabs.com) to commence work on supplying Imprimis with quantities of its active topical anti-inflammatory drug, Impracor, for currently planned Phase 3 clinical trials.  Impracor is the first drug to be developed using Imprimis's patented Accudel™ topical delivery technology.

Imprimis Pharmaceuticals, Inc. CEO Mark L. Baum stated, "Imprimis is pleased to have entered into an agreement for manufacturing our active Impracor clinical supplies from DPT Labs, a worldwide leader in the contract formulation and production of semi-solid pharmaceutical products.  This agreement was made in advance of planned Phase 3 clinical studies Imprimis intends to commence in the coming months.  Chief Medical Officer Dr. Joachim P.H. Schupp, added, "In addition to the production of Impracor, DPT Labs will also commence work on the formulation analysis and validation of the various quality assurance processes and procedures required for manufacturing Impracor as well as long-term stability testing.  DPT has been diligent in dealing with the technical and physicochemical property requirements of Impracor as well as the placebo material required for our studies."

"We are delighted to be chosen by Imprimis and we look forward to leveraging our expertise in semi-solids and liquids to support further execution of clinical development and manufacturing strategies for Impracor," stated Paul Josephs, DPT Senior Vice President Sales, Marketing & Corporate Development.

Baum concluded, "We are very confident that choosing DPT Labs will provide Imprimis with the best semi-solid production capabilities in the United States and the flexibility of s
'/>"/>

SOURCE Imprimis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
2. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
3. Access Pharmaceuticals To Host Second Quarter Investor Call on Thursday, August 23, 2012
4. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
5. Nouveau Life Pharmaceuticals (NOUV) Releases Calcium & Vitamin D for Strong Bones
6. Isis Pharmaceuticals Announces Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
7. Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
8. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
9. Intercept Pharmaceuticals Closes $30 Million Series C Financing
10. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
11. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015 Today, the California State Senate approved ... database before prescribing the most addictive medications to help ... SB 482, authored by Sen. Ricardo ... require prescribers to check the Controlled Substance Utilization Review ... III drugs, like OxyContin and other opioids, for the ...
(Date:5/28/2015)... ALEXANDRIA, Va. , May 28, 2015 ... Hoey , RPh, MBA issued the following statement in ... the AARP Public Policy Institute documenting that a number ... "This new report tracks with concerns previously expressed ... Congress to support patient access to essential medications. Moreover, ...
(Date:5/28/2015)... INDIANAPOLIS , May 28, 2015   Eli Lilly ... INCY ) will host a webcast on June 11 ... studies of baricitinib in rheumatoid arthritis. Data from these two trials, ... the Scientific Programme for the EULAR Congress 2015 in ... be held from 10:00 to11:00 a.m. Eastern Daylight Time. The ...
Breaking Medicine Technology:California Senate Approves Legislation Requiring Physicians To Check State Database Before Prescribing Powerful, Addictive Medications, Says Consumer Watchdog 2NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3
... LONDON and CRANBURY, N.J., Oct. 29 GlaxoSmithKline PLC ... today announced a definitive agreement to develop and commercialize ... for the treatment of Fabry disease, a rare inherited ... receive an exclusive worldwide license to develop, manufacture and ...
... Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will ... be held November 10-12, 2010 at the Arizona Biltmore Hotel ... scheduled to present an overview of the Company and its ... 2010. To listen to the audio web cast ...
Cached Medicine Technology:GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease 2GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease 3GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease 4GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease 5GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease 6Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 2Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 3
(Date:5/28/2015)... 28, 2015 New Jersey Plastic Surgeon ... delivering world-class results. With over 30 years of ... background in art, Dr. Rafizadeh knows what it takes ... to Plastic Surgery involves the principles of proportion, harmony ... superior level of comfort and personalized care from the ...
(Date:5/28/2015)... AMVETS leaders this week congratulated AMVETS ... Davis of Newark, Del. AMVETS National Commander Larry Via ... the $10,000 sweepstakes grand prize. , AMVETS selected the ... around the country for prizes ranging from $500 to ... May 21 at the AMVETS National Headquarters in Lanham, ...
(Date:5/28/2015)... May 28, 2015 Are policies that ... a hospital stay triggering financial pain for seniors? That’s ... Journal of Managed Care set to figure out, and ... federal rule change. , The study, “Observation Encounters and ... Vashi, MD, MPH, examined how Medicare policies that distinguish ...
(Date:5/28/2015)... May 28, 2015 Ross A. Clevens, ... , has hired Teresa Beard as the new marketing ... role, Beard will oversee all marketing and promotional events ... experience leading teams and developing compelling marketing strategies to ... Body Specialists, Beard served as guest communication manager at ...
(Date:5/28/2015)... Medelis, Inc., a specialty oncology CRO , today ... role of president. , “ Bill Taaffe has a ... Larry Flanagan, Medelis’ CEO and co-founder. “He will be a ... of growth.” , Taaffe joined ICON’s U.S. clinical operations ... over 4,500 employees, achieving 12 consecutive years of growth and ...
Breaking Medicine News(10 mins):Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 2Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 3Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2
... DALLAS, April 6 As consumers continue to adopt ... their guests by adding new menu items to their ... of the first casual dining restaurant concepts to create ... to healthier items in 1993. Along with the addition ...
... Against a background of economic uncertainty, people across the ... terms of their wealth but also their health, according ... practice of DDB Worldwide Communications Group Inc.The study, recently ... Omnicom Group Inc., compares perceptions about health among more ...
... the First of Five New Markets Slated to Feature ... April 6 MoleSafe ( www.molesafe.com ), a company that ... has opened its second U.S. location in Albuquerque, New Mexico. ... Jersey, in 2008. MoleSafe originated in New Zealand, which is ...
... Information Workflow Drives Carefx,s Agenda at HIMSS Conference, ... 6 Carefx Corporation , ... existing systems and offers clinicians single, clinically relevant ... at this year,s Healthcare Information and Management Systems ...
... fund multiple sclerosis researchCHICAGO, April 6 The Illinois ... for MS education and awareness by purchasing the newest ... 4, 2009, the Lottery released "Dash! For Cash" to ... Cash" is the second instant game created to support ...
... Phase Focuses On Integration Of Health Information Exchange ComponentsCHICAGO, ... Harris Corporation (NYSE: HRS ) has been ... Network (NHIN) CONNECT contract by the Federal Health Architect ... Office of the National Coordinator. CONNECT is an ...
Cached Medicine News:Health News:Chili's Celebrates Women with Curves 2Health News:DDB Worldwide and M/A/R/C Research Find in Time of Economic Crisis: Health Is the New Wealth, Survey Shows Empowering Patients Is Key to Influence 2Health News:MoleSafe USA Opens Second Location in Albuquerque, New Mexico 2Health News:MoleSafe USA Opens Second Location in Albuquerque, New Mexico 3Health News:Carefx Showcases Expanded Fusionfx Solution Suite and Profiles Changing Roles of CIOs at Executive Roundtable 2Health News:Carefx Showcases Expanded Fusionfx Solution Suite and Profiles Changing Roles of CIOs at Executive Roundtable 3Health News:Carefx Showcases Expanded Fusionfx Solution Suite and Profiles Changing Roles of CIOs at Executive Roundtable 4Health News:Illinois Lottery Releases New MS Ticket, Dash! For Cash 2Health News:Illinois Lottery Releases New MS Ticket, Dash! For Cash 3Health News:Harris Corporation Awarded Follow-on Contract Option to Expand CONNECT Solution for Nationwide Health Information Network 2Health News:Harris Corporation Awarded Follow-on Contract Option to Expand CONNECT Solution for Nationwide Health Information Network 3
Cross action, round handle, maximum opening 2.8 mm....
Cross action, round handle, maximum opening 2.8 mm....
Small pupil irrigating nucleus chopper, wedge-shaped inferior edge with, blunt tip and front notch, for engaging the iris, 0.6 mm dual sideports, 20 gauge....
Nucleus chopper. For bimanual nucleus division....
Medicine Products: